ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Neurotransmitter Uptake Inhibitors

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors 9 coordinate concepts 3 subordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Dopamine Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors ∟ Adrenergic Agents \| ∟ Cholinergic Agents \| ∟ Dopamine Agents \| ∟ Endocannabinoids \| ∟ Excitatory Amino Acid Agents \| ∟ GABA Agents \| ∟ Glycine Agents \| ∟ Histamine Agents \| ∟ Serotonin Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors 9 coordinate concepts 3 subordinate concepts ∟ Adrenergic Uptake Inhibitors \| ∟ Dopamine Uptake Inhibitors \| ∟ Serotonin Uptake Inhibitors ∟ Adrenergic Agents \| ∟ Cholinergic Agents \| ∟ Dopamine Agents \| ∟ Endocannabinoids \| ∟ Excitatory Amino Acid Agents \| ∟ GABA Agents \| ∟ Glycine Agents \| ∟ Histamine Agents \| ∟ Serotonin Agents X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Molecular Mechanisms of Action ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Neurotransmitter Agents ∟ Neurotransmitter Uptake Inhibitors Neurotransmitter Agents > Molecular Mechanisms of Action > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Neurotransmitter Agents > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Narrower terms:	Adrenergic Uptake Inhibitors \| Dopamine Uptake Inhibitors \| Serotonin Uptake Inhibitors X
Annotation:	GEN or unspecified; prefer specific groups or specific drugs; coord IM with specific neurotransmitters /physiol (IM); DF: NEUROTRANSM UPTAKE INHIB X
History note:	Cytoplasmic Granules (1966-1977) \| Kinetics (1966-1984) \| Nerve Endings (1966-1973) \| Synapses (1966-1971) \| Synaptic Vesicles (1972-1973) \| Synaptosomes (1974-1984)X
historyNote*:	93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92 X
onlineNote*:	use NEUROTRANSMITTER UPTAKE INHIBITORS to search TRANSMITTER UPTAKE INHIBITORS, NEURONAL; INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER 1985-92 X
publicMeSHNote*:	93; was TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92 X
Scope note:	Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1984-05-01X
dateEstablished*:	1985-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	SHX
Type:	Concept X
Coordinate terms:	Adrenergic Agents \| Cholinergic Agents \| Dopamine Agents \| Endocannabinoids \| Excitatory Amino Acid Agents \| GABA Agents \| Glycine Agents \| Histamine Agents \| Serotonin Agents X
URI:	X
Labels and equivalent concepts:	Välittäjäaineiden takaisinoton estäjät (fi) Transmitterin takaisinoton estäjä (fi, replaced) Transmittereiden takaisinoton inhibiittorit (fi, replaced) Transmitterin takaisinoton inhibiittori (fi, replaced) Välittäjäaineen takaisinoton estäjä (fi, replaced) Välittäjäaineiden takaisinoton inhibiittorit (fi, replaced) Välittäjäaineen takaisinoton inhibiittori (fi, replaced) Transmittereiden takaisinoton estäjät (fi, replaced) Neurotransmitterin takaisinoton inhibiittori (fi, replaced) Neurotransmitterien takaisinoton estäjät (fi, replaced) Neurotransmitterin takaisinoton estäjä (fi, replaced) Neurotransmitterien takaisinoton inhibiittorit (fi, replaced) Neurotransmittorupptagshämmare (sv) Transmitter Uptake Inhibitors, Neuronal (en, replaced) Reuptake Inhibitors, Neurotransmitter (en, replaced) Uptake Inhibitors, Neurotransmitter (en, replaced) Inhibitors, Neurotransmitter Uptake (en, replaced) X
Share:	X